Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A high index level often signals stronger market momentum or potential overbought conditions. Grasp its implications to adjust exposure and risk.
25,713 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A bold bet on the future of critical minerals. This article breaks down what metals company (tmc) could mean for your...
Alphabet’s investment arm quietly backs high-growth ventures. This deep dive explains why Alphabet owns million share...
Fermi’s stock jump today highlights how earnings, project milestones, and strategic pivots shape appetite for AI infr...
Novo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Stocks ride to record highs while bond yields climb. This article explains why treasury yields soaring that's driving...
A smart way to jump into AI semiconductors starts with a modest, well-balanced plan. Here are three no-brainer AI sto...
SpaceX sits at the frontier of aerospace and opportunity. This article breaks down the bold bets, the potential rewar...
The eVTOL craze mixes hype with real engineering, regulatory hurdles, and capital burn. Here's why I wouldn't touch t...
Looking for cash back with zero annual fees? These available credit cards offering cash back no fees rank high for si...
As markets ride a strong rally tied to policy expectations, a shift could come fast. This in-depth guide explains how...
Cerebras just pulled biggest IPO momentum sent shockwaves through tech stocks. This article breaks down what that imp...